Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)

SHA:603538 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,210	2,780	4,080	5,494	5,312	5,555
Market Cap Growth	4.44%	-31.86%	-25.74%	3.44%	-4.38%	50.31%
Enterprise Value	6,008	3,503	4,620	6,181	5,934	5,985
Last Close Price	23.70	12.68	19.04	25.44	24.99	26.13
PE Ratio	69.96	41.62	352.19	16.22	37.27	35.62
Forward PE	34.10	13.31	23.46	18.90	24.70	23.60
PS Ratio	3.76	2.03	3.35	3.77	4.22	4.66
PB Ratio	2.25	1.21	1.87	2.53	2.69	3.13
P/TBV Ratio	2.58	1.40	2.11	2.83	3.43	4.14
P/OCF Ratio	41.19	28.51	446.76	19.84	24.08	24.36
EV/Sales Ratio	4.33	2.55	3.80	4.24	4.72	5.02
EV/EBITDA Ratio	25.77	15.68	33.01	20.35	22.07	24.91
EV/EBIT Ratio	62.52	37.33	175.24	30.09	34.92	39.18
Debt / Equity Ratio	0.59	0.59	0.60	0.55	0.64	0.45
Debt / EBITDA Ratio	5.91	5.91	8.99	3.92	4.69	3.33
Asset Turnover	0.31	0.30	0.28	0.35	0.35	0.42
Inventory Turnover	1.25	1.37	1.45	1.52	1.53	1.85
Quick Ratio	0.58	0.71	0.80	0.90	0.90	0.56
Current Ratio	1.21	1.24	1.28	1.39	1.48	1.03
Return on Equity (ROE)	3.69%	3.40%	0.74%	17.71%	8.42%	9.67%
Return on Assets (ROA)	1.34%	1.29%	0.37%	3.05%	2.98%	3.33%
Return on Capital (ROIC)	1.67%	1.65%	0.48%	3.88%	3.65%	4.03%
Return on Capital Employed (ROCE)	3.20%	3.10%	0.90%	6.70%	6.00%	7.80%
Earnings Yield	1.42%	2.40%	0.28%	6.17%	2.68%	2.81%
FCF Yield	-0.31%	-2.94%	-5.16%	-5.36%	-5.82%	-1.59%
Dividend Yield	0.21%	0.39%	0.10%	0.65%	0.57%	-
Payout Ratio	32.75%	34.00%	511.34%	14.76%	9.71%	26.61%
Buyback Yield / Dilution	5.10%	6.99%	-1.89%	-6.91%	-3.50%	-0.07%
Total Shareholder Return	5.29%	7.39%	-1.78%	-6.26%	-2.93%	-0.07%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.